Purple Biotech Ltd (PPBT) Return on Investment ROI from the fourth quarter of 2024 to fourth quarter of 2022 and for the year 2024, average high and low, overall ranking from Dec 31 2024 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Purple Biotech Ltd  (NASDAQ: PPBT)


Purple Biotech Ltd's ROI from its fourth quarter of 2024 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Purple Biotech Ltd's ROI in the fourth quarter of 2024?
Purple Biotech Ltd achieved a return on average invested assets (ROI) of 26.86 % in its fourth quarter of 2024, which is below Purple Biotech Ltd's average return on investment, which stands at 38.78%.

ROI fell compared to the third quarter of 2024, despite the net income growth of % from the third quarter of 2024.

Within the Healthcare sector 50 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2024 from to 289.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Investment Change TTM -32.84 % -25.03 % -29.39 % -44.71 % -43.39 %
Y / Y Net Income Change TTM -66.55 % 17.83 % 17.83 % 17.83 % 17.83 %
Investment (TTM) in Millions 10 33 33 33 33
Return On Investment (TTM) 26.86 % 66.12 % 65.43 % 59.12 % 53.93 %
PPBT's Overall Ranking # 289 # # # #
Seq. Investment Change TTM -17.66 % -1.04 % -9.64 % -8.79 % -8.08 %
Seq. Net Income Change TTM -66.55 % 0 % 0 % 0 % 17.83 %
Net Income (TTM) in Millions 7 22 22 22 22

PPBT Company Profile >> Back to PPBT Roi Comparisons >> See Annual PPBT Return On Investment



Return On Investment PPBT's Ranking
Within: No.
Industry # 22
Sector # 51
Overall # 289

Return On Investment Statistics
High Average Low
52.75 %
38.78 %
22.12 %
(Dec 31 2019)   (Dec 31 2024)







Financial Statements
Purple Biotech Ltd's IV. Quarter Investments $ 10 Millions PPBT's Balance sheet
Purple Biotech Ltd's IV. Quarter Income $ 7 Millions Quarterly PPBT's Income Statement
PPBT's Income by Division See PPBT's Income by Division


PPBT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 10 33 34 47 125
Y / Y Investment Growth -70.65 % -4.04 % -27.18 % -62.31 % 2.66 %
Net Income in Millions -26 -7 -20 -22 18
Y / Y Net Income Growth - - - - -34.22 %
Annual Return On Investment -274.27 % -22.12 % -58.25 % -46.2 % 14.78 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PPBT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PPBT's Competitors
Subscribers only: Roi for Purple Biotech Ltd's Suppliers
Subscribers only: Return On Investment for PPBT's Customers

Other Ratios
PPBT's Roa PPBT's Inventory Turnover Ratio PPBT's Growth Rates PPBT's Dividend Statistics
PPBT's Profitability Ratios PPBT's Asset Turnover Ratio PPBT's Dividend Growth
PPBT's Roe PPBT's Valuation Ratios PPBT's Financial Strength Ratios PPBT's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2024, within Healthcare Sector ROI
Tao Synergies Inc   71.64 %
Gridai Technologies Corp  62.11 %
Adma Biologics Inc   57.87 %
Agios Pharmaceuticals Inc   56.44 %
Exelixis Inc   48.27 %
Biomx Inc  47.46 %
Galmed Pharmaceuticals Ltd   45.92 %
Protagonist Therapeutics inc   45.50 %
Sbc Medical Group Holdings Incorporated  44.70 %
Mettler toledo International Inc   41.47 %
Edwards Lifesciences Corporation  41.33 %
Dariohealth Corp   40.59 %
Idexx Laboratories Inc  37.76 %
Medpace Holdings Inc   37.38 %
Acadia Pharmaceuticals Inc   35.85 %
Semler Scientific inc   34.43 %
Pharmacyte Biotech Inc   32.98 %
Siga Technologies Inc  32.37 %
Hims and Hers Health Inc   30.09 %
Promis Neurosciences inc   29.63 %
Nrc Health  29.39 %
Entrada Therapeutics Inc   29.29 %
Medinotec Inc   29.11 %
Gsk Plc  28.34 %
Puma Biotechnology Inc   26.40 %
Carlisle Companies Incorporated  26.39 %
Catalyst Pharmaceuticals Inc   25.42 %
Inmode Ltd   25.32 %
Engene Therapeutics Inc   24.80 %
Halozyme Therapeutics Inc   23.75 %

Date modified: 2026-09-02T18:44:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.